Whether bone marrow stromal cells of donors contribute physiologically to hematopoietic stem cell reconstitution after marrow transplantation is unknown. To determine the transplantability of nonhematopoietic marrow stromal cells, stable clonal stromal cell line (GB1/6) expressing the a isoenzyme of glucose-6-phosphate isomerase (Glu6PI-a, D-glucose-6-phosphate ketol-isomerase; EC 5.3
in the absence of detectable growth factors interleukin 3 (multi-colony-stimulating factor), granulocyte/macrophage colony-stimulating factor, granulocyte-stimulating factor, or their poly(A)+ mRNAs. The GB1/6 cells produced macrophage colony-stimulating factor constitutively. Recipient C57BL/6J (glucose-6-phosphate isomerase b) mice that received 3-Gy total-body irradiation and 13 Gy to the right hind limb were injected i.v. with GB1/6 cells. Engrafted mice demonstrated donor-originating Glu6PI-a+ stromal cells in marrow sinuses in situ 2 mo after transplantation and a significantly enhanced hematopoietic recovery compared with control irradiated nontransplanted mice. Continuous (over numerous passages) marrow cultures derived from transplanted mice demonstrated G418-resistant, Glu6PI-a+ stromal colony-forming cells and greater cumulative production of multipotential stem cells of recipient origin compared with cultures established from irradiated, nontransplanted control mice. These data are evidence for physiological function in vivo of a transplanted bone marrow stromal cell line.
Successful transplantation of bone marrow stem cells relies on their ability to proliferate and differentiate in contact with stromal cells of the microenvironment. Total-body irradiation (TBI) and/or treatment with chemotherapeutic alkylating agents before transplantation of autologous or allogeneic stem cells does not always allow hematopoietic recovery due to functional change in the recipient's marrow stromal cells (1) . Correcting the defective marrow stroma by transplantation of marrow stromal cells is one theoretical therapy. Several earlier reports suggest that marrow stromal cells can be transplanted in vivo. Werts et al. (2) reported that irradiated mouse limbs were reconstituted by stromal cell progenitors migrating through the circulation. Donor-originating marrow fibroblasts have been detected in lethally irradiated mice after i.v. bone marrow transplantation (2) (3) (4) . Long-term marrow cultures (LBMCs) established from human marrow transplant patients, revealed donor-originating fibroblastic and endothelial cells (5) . In contrast, other studies have failed to show donor-originating stromal cells after bone marrow transplantation (6) (7) (8) .
MATERIALS AND METHODS
Derivation and Characterization of Stable Marrow Stromal Cell Lines and Test of Physiological Function in Vitro. To establish a stromal cell line with a dominant selectable marker, the neomycin-resistance gene was transferred by a retroviral vector (10) to a cell line GB1/6 established from the adherent layer of LBMCs from B6Cast (Glu6PI-a) mice (9) as described (11) . A subclone GBlneor containing the neor gene was selected in G418 (500 jig/ml) and expanded in vitro.
Staining for alkaline phosphatase, acid phosphatase, peroxidase, a-naphthyl esterase, and lysozyme was done as described (12) . Antisera to extracellular matrix proteins laminin, fibronectin (Collaborative Research, Waltham, MA), collagen types I and IV, and the alloenzyme marker Glu6PI-a (13) identified each protein in the GB1/6 cell line using each specific antiserum and the immunoperoxidase technique (14) . For immunohistological studies, proximal tibiae were collected, split longitudinally, and fixed for 18 hr in 2% paraformaldehyde/0.1 M cacodylate buffer, pH 7.4. Bones were decalcified in 0.3 M EDTA/0.1 M cacodylate buffer, pH 7.4, for 4 days. Paraffin-embedded bones were sectioned at 5 ,um and stained for reactivity with rabbit antiserum against mouse Glu6PI-a and indirect immunoperoxidase staining (14) . Total cellular RNA isolated from the GBlneor stromal cell line was used to prepare poly(A)+ mRNA by a modification ofthe guanidine hydrochloride extraction method (15) .
Specific message for interleukin 3 (IL-3) (16), granulocyte/ macrophage colony-stimulating factor (GM-CSF) (17) , macrophage colony-stimulating factor (M-CSF) (18), IL-1 (19) , and granulocyte colony-stimulating factor (G-CSF) (20) was identified by hybridization with specific cDNA probes (>108 cpm/,4g) as described (15) . Methods for marrow transplantation in vitro and hematopoietic cell assays have also been described (11, (21) (22) 
RESULTS
Characterization of the GB1/6 Stromal Cell Line. Analysis of confluent cultures by phase microscopy often showed large binucleate cells. The presence of the Glu6PI-a isoenzyme was identified in 100% of the GB1/6 cells using specific antiserum. GB1/6 stromal cells were also assayed for expression of cytoplasmic enzymes and were positive for anaphthyl acetate esterase and acid phosphatase and negative for peroxidase and alkaline phosphatase (data not shown). Extracellular matrix components produced by GB1/6 cells included fibronectin, laminin, and collagen type IV, with no detectable collagen type I (data not shown). When these data for cell line GB1/6 were compared with several other stromal cell lines including MBA-1, MBA-13, 14F-1 (23), and D2XRII (10), the cell line was classified as endothelial-like based on published criteria (23) . GBineor cells had cytochemical properties and extracellular matrix proteins indistinguishable from those of GB1/6 cells. Newborn C57BL/6J and sublethally irradiated adult C57BL/6J mice injected with 5 x 106 to 1 x 107 GB1/6 cells did not show detectable tumors after 6 mo (data not shown).
GB1/6 cells were tested for support of purified hematopoietic progenitor cells in vitro. Fig. 1 shows that hematopoietic progenitor cells were supported over 4 weeks. The cumulative number of CFU-S-forming progenitors produced was 23.1 + 6.1 per flask and colony-forming unit of granulocyte, erythrocyte, macrophage/megakaryocytes (CFU-GEMM)-forming progenitors was 81.4 ± 36.2 x 102 per flask ( Fig. 1) . Further, the GB1/6 cell line supported growth of IL-3-dependent multipotential hematopoietic progenitor cell line B6SUtA (17) (27) . CFU-S colonies were scored on day 14 To determine whether the hematopoietic support capacity of GB1/6 and GBlneor cells was due to production of a known colony-stimulating factor (CSF), and in particular IL-3, poly(A)+ mRNA from GBlneor cells was analyzed by RNA blot hybridization, for mRNA of known growth factors. GBlneor cells had no detectable poly(A)+ mRNA for IL-3, GM-CSF, G-CSF, or IL-1; but the cells had detectable poly(A)+ mRNA for M-CSF (data not shown). Thus, the hematopoietic support capacity of GB1/6 cell line in vitro could not be attributed to the synthesis of detectable quantities of any known hematopoietin with multi-CSF activity.
Homing and Function of GB1/6 Cells in Transplanted Mice.
The ability of injected stromal cells to "home" and stably seed into marrow sinuses in vivo was first evaluated by in vivo immunohistochemical technique. Glu6PI-a' stromal cells were identified in situ 2 mo after transplant in the RHL marrow sinuses of transplanted mice. Two months after transplantation neither engrafted nor irradiated nonengrafted control mice demonstrated detectable donor-originating Glu6PI-a cells in spleen, liver, lung, or peritoneal washings (data not shown). As shown in Table 1 and Fig. 2 Explanted marrow cells from control-irradiated nontransplanted mice and mice transplanted with GBlneor cells were selected for growth in G418 (500 ,ug/ml). Table 2 shows that G418-resistant stromal cell colonies were found in the explanted RHL marrow of transplanted, but not of controlirradiated mice.
The physiological function in vitro of transplanted GB1/6 stromal cells was next evaluated. At monthly intervals LBMCs were established individually from each hind limb of GB1/6-transplanted and -irradiated nonengrafted control mice. The functional integrity of the adherent stromal cells was quantitated by measuring the longevity of hematopoiesis as cumulative number of total nonadherent cells and multi- Fig. 3B ).
The effect of donor stromal cell number injected on recovery of hematopoiesis in irradiated mice was next tested. Fig. 4 shows that LBMCs from the RHL (13 Gy) of irradiated nontransplanted control mice produced 11.45 ± 4.8 x 105 cells per flask (Fig. 4A ) and 7.41 ± 0.8 x 102 CFU-GEMM progenitors per flask (Fig. 4C) . The cumulative production of nonadherent cells as well as the CFU-GEMM progenitor cells in LBMCs from RHL marrow cultures of transplanted mice increased with the number of stromal cells injected per mouse over the range of 1 x 105-1 X 106 cells (Fig. 4 A and C) .
Production of hematopoietic progenitor cells by RHL cultures from transplanted mice reached 48% of the level seen in cultures from nonirradiated mice compared with 5% by marrow cultures from irradiated nontransplanted mice ( 4 A and C). An x-ray dose of 3 Gy to the left hind limb decreased hematopoietic stem cell production in marrow cultures from irradiated nontransplanted mice to 35% compared with cultures from nonirradiated mice. However, GB1/6 cell engraftment did not detectably increase cell production in LBMCs from limbs irradiated at this dose (Fig.  4 BandD).
The efficiency of repopulation of marrow sinuses of the RHL (13 Gy) by endogenous CFU-S and the recovery of peripheral blood counts was next measured in GB1/6 celltransplanted and in irradiated nontransplanted control mice. Groups of C57BL/6J mice were irradiated in 2-Gy increments from 3 Gy to 7 Gy with the RHL receiving between 10 and 12.5 Gy (Table 3) . A subgroup from each irradiation dose group was injected with 5 x 105 GB1/6 cells per mouse (optimal cell inoculum based on data in Fig. 4 A and C) . Six weeks after irradiation and transplantation, the RHL from each animal in each dose group was assayed for the number of multipotential stem cells forming CFU-S. As shown in Table 3 at lower TBI doses of 3 and 5 Gy, the number of CFU-S-forming multipotential stem cells per RHL was similar in GB1/6 transplanted and in control irradiated nontransplanted mice. In contrast, sublethally irradiated (7-Gy TBI) mice transplanted with GB1/6 cells showed a significantly higher number of stem cells forming CFU-S in the RHL compared with the number recovered from the RHL of irradiated nontransplanted control mice (P < 0.01).
The kinetics of recovery of peripheral blood counts in mice after TBI doses of 3 or 5 Gy were similar in transplanted and control irradiated nontransplanted mice (Table 3 ). In contrast, a significant recovery of peripheral blood white blood cell count (6.9 ± 1.0 x 103 per mm3) and platelet count (112.5 ± 2.5 x 103 per mm3) was seen in 7-Gy-irradiated GB1/6-transplanted mice compared with irradiated nontransplanted controls (white blood cell count: 4 ± 0.05 x 103 cells per mm3;
platelet count 50 ± 3 platelets per mm3; P < 0.05; Table 3 ).
DISCUSSION
The function of donor-originating stromal cells in the marrow-transplant recipient is unknown. The data show a stable murine stromal cell line that provides a favorable microenvironment for hematopoietic stem cells in vitro, engrafts in vivo in irradiated recipients, and stimulates recovery of recipient hematopoietic stem cells in vivo. Using specific antiserum against the Glu6PI-a isoenzyme, stromal cells of donor origin were identified in marrow sinuses in situ as well as in adherent cells explanted in vitro several months after transplant. Thus, donor-originating stromal cells can infil- 0.6) (108.0 ± 1.0) (7.4 ± 0.12) 7.0 101.8 ± 11.7 § 6.9 ± 1.01 112.5 ± 2.51 7.5 ± 0.5 (49.1 ± 9.5) (4.0 ± 0.05) (50.0 ± 3.0) (5.9 ± 1.3) *Each irradiation group had 5-10 mice per group. All mice received an additional 10-12.5 Gy to the RHL. One group was injected with 5 x 106 GB1/6 stromal cells per mouse. Values in parentheses are from the group that received no cells but were control irradiated. tSix weeks after irradiation and transplantation, a subgroup from each group was sacrificed; cells were flushed from each RHL and assayed for CFU-S (21) . Results are expressed as mean ± SD of three to five mice. An average of 4.4 ± 2.9 endogenous CFU-S colonies was seen on the spleens of irradiated noninjected mice. tResults are expressed as mean + SD of at least three mice per group. Nonirradiated mice had a white blood cell (WBC) count of 8. trate host marrow sinuses and function in vivo to support recovery of primitive hematopoietic stem cells including those forming CFU-S and CFU-GEMM. Whether stimulation of CFU-S recovery by GB1/6 cells in inoculated mice can be attributed to stimulation of CFUs at the irradiation site in proximity to seeded GB1/6 cells, to homing of CFU-S arriving via the circulation from other sites, or to both mechanisms is unknown.
The GB1/6 cell line was chosen for these studies because of its endothelial-like characteristics and in vitro support capacity for multipotential hematopoietic progenitor cells. Constitutive production of M-CSF and no detectable production of IL-3, GM-CSF, nor G-CSF suggests that its support capacity for stem cells may be due either to the ability of M-CSF to trigger release of other CSFs from accessory cells in vivo and in vitro (24) or to another growth factor. Other clonal stromal cell lines demonstrated by us (11) and others (25) do not support multipotential hematopoietic progenitor cells forming CFU-S in vitro. Whether these other cell lines also engraft in vivo and support or suppress hematopoietic recovery after irradiation is unclear.
Marrow cultures established in vitro from the heavily irradiated RHL (13 Gy) of mice transplanted with GB1/6 cells showed stable engraftment of donor stromal cells over 3 mo and enhanced hematopoietic progenitor cell production in vitro in LBMCs compared with cultures derived from irradiated nontransplanted control mice. In contrast, hematopoiesis in LBMCs established from the 3-Gy-irradiated left hind limb of transplanted mice was not enhanced compared with cultures from irradiated nontransplanted control mice, and donor-originating stromal cells identified at 1 mo did not persist. The data confirm that previous irradiation damages the stromal cells of the hematopoietic microenvironment (26) and support Brecher et al. (27) , who suggested that niches, freed of endogenous hematopoietic stem cells by the higher dose, provide more efficient seeding sites for injected donor cells. Our data may explain previous failure to detect donororiginating stromal cells in studies using lower x-ray doses (6, 
8).
To establish a detectable chimeric stromal cell population, a minimum of 1 x 105 purified GB1/6 stromal cells were required. Thus, other studies reporting no donor-originating stromal cells in LBMC adherent cell layers derived from transplanted mice using chromosomally marked marrow cells may not have used enough transplanted cells.
The physiological failure of bone marrow has generally been attributed to defects in the hematopoietic stem cellsdefects correctable by autologous or allogenic bone marrowstem cell transplantation (28) . However, the pathophysiology of some forms of marrow failure, as in chronic myelogenous leukemia (29) and aplastic anemia (30, 31) , may be due to a defect in the stromal microenvironment. Our data revealed evidence for stimulation of hematopoietic recovery in vivo in stromal cell line-engrafted mice compared with irradiated nontransplanted controls. Although further studies are required, a therapeutic role for stromal cell infusion in conjunction with hematopoietic stem cell transplantation is suggested in the treatment of some forms of marrow failure.
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